HelixBind_Logo_AS2-no BG (2018).png
HelixBind Awarded $3MM NIH Grant to Support Testing of Its RaPID Diagnostic Platform for Invasive Infections Associated with Sepsis
June 17, 2021 08:30 ET | HelixBind
BOXBOROUGH, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
Reports and Data.jpeg-01
Hospital Acquired Infections (HAI) Diagnostics Market To Reach USD 5.68 Billion By 2027 | Reports and Data
August 31, 2020 19:00 ET | Reports and Data
New York, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The global Hospital Acquired Infections (HAI) Diagnostics market is forecast to reach USD 5.68 Billion by 2027, according to a new report by Reports and...
HelixBind_Logo_AS2-no BG (2018).png
FDA Grants HelixBind Breakthrough Device Designation for RaPID Sepsis Test
August 24, 2020 11:47 ET | HelixBind
BOXBOROUGH, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
HelixBind_Logo_AS2-no BG (2018).png
HelixBind Awarded $3MM Grant from NIH for New Rapid Test for the Early Detection of Lyme Disease
July 16, 2020 12:01 ET | HelixBind
BOXBOROUGH, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for patients afflicted with invasive microbial infections,...
HelixBind_Logo_AS2-no BG (2018).png
HelixBind Awarded $3MM Grant from NIH and Expands Clinical Advisory Board to Accelerate Development of Its Diagnostic Platform for Invasive Infections
June 10, 2020 10:29 ET | HelixBind
BOXBOROUGH, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...